10-Q Filing

REGENXBIO Inc. CIK: 1590877 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001564590-16-028642`
Period End Date	20160930
Filing Date	20161109
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	rgnx-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 89 Cash Flow Statement 65

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$205.32M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.11M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$63.66M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$60.02M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$2.14M	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$679.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.17M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.02M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$851.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.31M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.48M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.31M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$96.62M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.48M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$118.15M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$93.09M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$102.23M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$538.00K	USD	Point-in-time
Cost method investments	`CostMethodInvestments`	$300.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$225.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$168.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$239.00K	USD	Point-in-time
Total assets	`Assets`	$221.38M	USD	Point-in-time
Total assets	`Assets`	$195.97M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.01M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$3.20M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$9.01M	USD	Point-in-time
Advance payments	`CustomerAdvancesCurrent`	$127.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.34M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$233.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.37M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.75M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.57M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at September 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at September 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2016 and December 31, 2015; 26,475 and 26,313 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2016 and December 31, 2015; 26,475 and 26,313 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$269.14M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$274.35M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$853.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-719.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-51.62M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-94.98M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$180.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$216.81M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$221.38M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$195.97M	USD	Point-in-time

Income Statement 89 line items

Line Item	Tag	Value	Unit	Period
License revenue	`LicensesRevenue`	$65.00K	USD	1 Quarter
License revenue	`LicensesRevenue`	$65.00K	USD	1 Quarter
License revenue	`LicensesRevenue`	$2.64M	USD	3 Qtrs
License revenue	`LicensesRevenue`	$635.00K	USD	3 Qtrs
License revenue from related party	`RevenueFromRelatedParties`	$2.00M	USD	3 Qtrs
License revenue from related party	`RevenueFromRelatedParties`	$1.00M	USD	1 Quarter
Reagent sales	`OtherSalesRevenueNet`	$213.00K	USD	3 Qtrs
Reagent sales	`OtherSalesRevenueNet`	$200.00K	USD	3 Qtrs
Reagent sales	`OtherSalesRevenueNet`	$61.00K	USD	1 Quarter
Reagent sales	`OtherSalesRevenueNet`	$47.00K	USD	1 Quarter
Grant revenue	`GrantsRevenueExpenses`	$305.00K	USD	3 Qtrs
Grant revenue	`GrantsRevenueExpenses`	$42.00K	USD	3 Qtrs
Grant revenue	`GrantsRevenueExpenses`	$13.00K	USD	1 Quarter
Grant revenue	`GrantsRevenueExpenses`	$14.00K	USD	1 Quarter
Total revenues	`Revenues`	$1.14M	USD	1 Quarter
Total revenues	`Revenues`	$2.89M	USD	3 Qtrs
Total revenues	`Revenues`	$125.00K	USD	1 Quarter
Total revenues	`Revenues`	$3.14M	USD	3 Qtrs
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$13.00K	USD	1 Quarter
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$528.00K	USD	3 Qtrs
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$213.00K	USD	1 Quarter
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$527.00K	USD	3 Qtrs
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$44.00K	USD	1 Quarter
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$22.00K	USD	1 Quarter
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$101.00K	USD	3 Qtrs
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$94.00K	USD	3 Qtrs
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$5.66M	USD	1 Quarter
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$29.42M	USD	3 Qtrs
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$12.56M	USD	1 Quarter
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$12.47M	USD	3 Qtrs
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$2.57M	USD	1 Quarter
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$7.67M	USD	3 Qtrs
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$6.20M	USD	1 Quarter
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$17.85M	USD	3 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$136.00K	USD	3 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$2.00K	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$1.00K	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-15.00K	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$18.79M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$8.49M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$47.76M	USD	3 Qtrs
Total operating expenses	`CostsAndExpenses`	$20.78M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-44.87M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-17.64M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-18.67M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.35M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$23.00K	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$1.51M	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$15.00K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$514.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$20.00K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$15.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$1.51M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$3.00K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$514.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.64M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-18.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-7.33M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-26.00K	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.57M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$332.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-26.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-26.00K	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.57M	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-26.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$332.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-41.79M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.66M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.36M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.64M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-18.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-7.33M	USD	1 Quarter
Net accretion and dividends on convertible preferred stock	`PreferredStockDividendsAndOtherAdjustments`	$1.75M	USD	3 Qtrs
Net gain on extinguishment of convertible preferred stock	`NetGainOnExtinguishmentOfPreferredStockForEarningsPerShare`	$759.00K	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-43.36M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.62M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.33M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.15M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.69	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-5.48	USD	3 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.52	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.64	USD	3 Qtrs
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.81M	shares	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.39M	shares	3 Qtrs
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.40M	shares	3 Qtrs
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.47M	shares	1 Quarter

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-17.64M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-18.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-7.33M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$5.03M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$2.06M	USD	3 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.00K	USD	3 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.50M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$43.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$264.00K	USD	3 Qtrs
Realized gains on sales of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$20.00K	USD	3 Qtrs
Unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossUnrealized`	$4.00K	USD	3 Qtrs
Unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossUnrealized`	$2.00K	USD	3 Qtrs
Imputed interest on related party promissory notes	`ImputedInterestOnRelatedPartyDebt`	$13.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.28M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.46M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.37M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.15M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.15M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$127.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$71.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$128.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$3.60M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$317.00K	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$758.00K	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$4.59M	USD	3 Qtrs
Due to related party under services agreement	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-34.00K	USD	3 Qtrs
Other related party payables	`IncreaseDecreaseInDueToOtherRelatedPartiesCurrent`	$-3.41M	USD	3 Qtrs
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$-26.00K	USD	3 Qtrs
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$-127.00K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$1.30M	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$198.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-28.14M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-18.07M	USD	3 Qtrs
Restricted cash	`IncreaseDecreaseInRestrictedCash`	$225.00K	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$32.26M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$19.07M	USD	3 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$38.13M	USD	3 Qtrs
Sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$23.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$394.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.71M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-19.46M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$1.95M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$174.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$100.00K	USD	3 Qtrs
Proceeds from initial public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuanceInitialPublicOffering`	$148.23M	USD	3 Qtrs
Issuance costs for initial public offering	`PaymentsOfStockIssuanceCosts`	$618.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$174.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$241.73M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-26.01M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$204.20M	USD	3 Qtrs
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$205.32M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$28.11M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$205.32M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$28.11M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$7.00K	USD	3 Qtrs
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$34.00K	USD	3 Qtrs
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.82M	USD	3 Qtrs
Issuance costs for initial public offering in accounts payable and accrued expenses	`IssuanceCostsForInitialPublicOfferingInAccountsPayableAndAccruedExpenses`	$2.43M	USD	3 Qtrs
Conversion of related party promissory notes into Series C convertible preferred stock	`DebtConversionConvertedInstrumentAmount1`	$1.39M	USD	3 Qtrs
Conversion of convertible preferred stock into common stock upon initial public offering	`ConversionOfStockAmountConverted1`	$111.39M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.